Literature DB >> 26481666

Comparison of Hypoalgesic Effects of Neural Stretching vs Neural Gliding: A Randomized Controlled Trial.

Hector Beltran-Alacreu1, Laura Jiménez-Sanz2, Josue Fernández Carnero3, Roy La Touche4.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the immediate mechanical hypoalgesic effect of neural mobilization in asymptomatic subjects. We also compared neural gliding vs neural stretching to see which produced greater hypoalgesic effects in asymptomatic subjects.
METHODS: Forty-five asymptomatic subjects (20 men and 25 women; mean ± SD age, 20.8 ± 2.83 years) were randomly allocated into 3 groups: the neural glide group, the neural stretch group, and the placebo group. Each subject received 1 treatment session. Outcome measures included bilateral pressure pain threshold measured at the trigeminal, cervical, and tibialis anterior points, assessed pre-treatment and immediately post-treatment by a blinded assessor. Three-way repeated-measures analysis of variance was used to evaluate changes in pressure pain threshold, with group (experimental or control) as the between-subjects variable and time (pre-, post-treatment) or side (dominant, nondominant) as the within-subjects variable.
RESULTS: Group differences were identified between neural mobilization groups and the placebo group. Changes occurred in all of the pressure pain threshold measures for neural gliding, and in all but the trigeminal point for neural stretch. No changes in the pressure pain threshold measures occurred in the placebo group.
CONCLUSIONS: This research provides new experimental evidence that neural mobilization produces an immediate widespread hypoalgesic effect vs placebo but neural gliding produces hypoalgesic effects in more body sites than neural stretching.
Copyright © 2015 National University of Health Sciences. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Manual Therapy; Nociception; Pain

Mesh:

Year:  2015        PMID: 26481666     DOI: 10.1016/j.jmpt.2015.09.002

Source DB:  PubMed          Journal:  J Manipulative Physiol Ther        ISSN: 0161-4754            Impact factor:   1.437


  6 in total

1.  Neurodynamic Treatment Promotes Mechanical Pain Modulation in Sensory Neurons and Nerve Regeneration in Rats.

Authors:  Giacomo Carta; Benedetta Elena Fornasari; Federica Fregnan; Giulia Ronchi; Stefano De Zanet; Luisa Muratori; Giulia Nato; Marco Fogli; Giovanna Gambarotta; Stefano Geuna; Stefania Raimondo
Journal:  Biomedicines       Date:  2022-05-31

Review 2.  Rehabilitation of hamstring muscle injuries: a literature review.

Authors:  Gabriel Amorim Ramos; Gustavo Gonçalves Arliani; Diego Costa Astur; Alberto de Castro Pochini; Benno Ejnisman; Moisés Cohen
Journal:  Rev Bras Ortop       Date:  2016-12-15

Review 3.  Update on Efficacy of Conservative Treatments for Carpal Tunnel Syndrome.

Authors:  Teemu Karjalanen; Saara Raatikainen; Kati Jaatinen; Vieda Lusa
Journal:  J Clin Med       Date:  2022-02-11       Impact factor: 4.241

4.  Comparative effects of tensioning and sliding neural mobilization on peripheral and autonomic nervous system function: A randomized controlled trial.

Authors:  Budour Yousif Alharmoodi; Ashokan Arumugam; Amal Ahbouch; Ibrahim M Moustafa
Journal:  Hong Kong Physiother J       Date:  2022-03-17

5.  Neurotrophin expression and histomorphometric evaluation in Wistar rats subjected to neural mobilization after compression of the median nerve.

Authors:  Marieli Araujo Rossoni Marcioli; José Luis da Conceição Silva; Lucinéia de Fátima Chasko Ribeiro; Rose Meire Costa Brancalhão; Gladson Ricardo Flor Bertolini
Journal:  Rev Bras Ortop       Date:  2018-04-04

6.  Effectiveness of neural mobilization on pain intensity, disability, and physical performance in adults with musculoskeletal pain-A protocol for a systematic review of randomized and quasi-randomized controlled trials and planned meta-analysis.

Authors:  Frederico Mesquita Baptista; Eduardo Brazete Cruz; Vera Afreixo; Anabela G Silva
Journal:  PLoS One       Date:  2022-03-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.